Detalhe da pesquisa
1.
Dietary intake during a pragmatic cluster-randomized weight loss trial in an underserved population in primary care.
Nutr J
; 22(1): 38, 2023 08 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37528391
2.
Pax4 in Health and Diabetes.
Int J Mol Sci
; 24(9)2023 May 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37175989
3.
Type 2 Diabetes and Hypertension.
Circ Res
; 124(6): 930-937, 2019 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30646822
4.
Blockade of sodium-glucose cotransporter 2 suppresses high glucose-induced angiotensinogen augmentation in renal proximal tubular cells.
Am J Physiol Renal Physiol
; 318(1): F67-F75, 2020 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31682172
5.
A Systematic Review of Cost-Effectiveness of Sodium-Glucose Cotransporter Inhibitors for Type 2 Diabetes.
Curr Diab Rep
; 20(4): 12, 2020 03 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32166504
6.
Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Management of Dyslipidemia and Prevention of Cardiovascular Disease Algorithm - 2020 Executive Summary.
Endocr Pract
; 26(10): 1196-1224, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-33471721
7.
Canagliflozin Prevents Intrarenal Angiotensinogen Augmentation and Mitigates Kidney Injury and Hypertension in Mouse Model of Type 2 Diabetes Mellitus.
Am J Nephrol
; 49(4): 331-342, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30921791
8.
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY 2018 POSITION STATEMENT ON INTEGRATION OF INSULIN PUMPS AND CONTINUOUS GLUCOSE MONITORING IN PATIENTS WITH DIABETES MELLITUS.
Endocr Pract
; 24(3): 302-308, 2018 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-29547046
9.
PAX4 Gene Transfer Induces α-to-ß Cell Phenotypic Conversion and Confers Therapeutic Benefits for Diabetes Treatment.
Mol Ther
; 24(2): 251-260, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26435408
10.
AACE/ACE POSITION STATEMENT ON THE USE OF FOLLOW-ON BIOLOGICS AND BIOSIMILARS FOR ENDOCRINE DISEASES.
Endocr Pract
; 23(11): 1345-1349, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-29190135
11.
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE.
Endocr Pract
; 23(Suppl 2): 1-87, 2017 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-28437620
12.
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE - EXECUTIVE SUMMARYComplete Appendix to Guidelines available at http://journals.aace.com.
Endocr Pract
; 23(4): 479-497, 2017 Apr 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28156151
13.
What Are We Learning from the FDA-Mandated Cardiovascular Outcome Studies for New Pharmacological Antidiabetic Agents?
Curr Diab Rep
; 16(10): 94, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27541296
14.
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY POSITION STATEMENT ON THE ASSOCIATION OF SGLT-2 INHIBITORS AND DIABETIC KETOACIDOSIS.
Endocr Pract
; 22(6): 753-62, 2016 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-27082665
15.
CONTINUOUS GLUCOSE MONITORING: A CONSENSUS CONFERENCE OF THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY.
Endocr Pract
; 22(8): 1008-21, 2016 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-27214060
16.
Rationale for the Use of Combination Injectable Therapy in Patients With Type 2 Diabetes Who Have High A1C (≥9%) and/or Long Duration (>8 Years): Executive Summary.
Clin Diabetes
; 39(2): 141-145, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33986566
17.
GLYCATED ALBUMIN AT 4 WEEKS CORRELATES WITH A1C LEVELS AT 12 WEEKS AND REFLECTS SHORT-TERM GLUCOSE FLUCTUATIONS.
Endocr Pract
; 21(11): 1195-203, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26214108
18.
Progressive change of intra-islet GLP-1 production during diabetes development.
Diabetes Metab Res Rev
; 30(8): 661-8, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24510483
19.
CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2019 EXECUTIVE SUMMARY.
Endocr Pract
; 25(1): 69-100, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30742570
20.
Update on Safety Issues Related to Antihyperglycemic Therapy.
Diabetes Spectr
; 27(2): 92-100, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-26246765